Cormedics
Cormedics develops novel technologies that treat the heart with drugs, cells, genes, and device therapies.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD1—2m (Dealroom.co estimates Sep 2011.)
Houston Texas (HQ)
Authorizing premium user...